Gastrointestinal bleeding risk with rivaroxaban vs aspirin in atrial fibrillation: A multinational study
© 2020 The Authors. Pharmacoepidemiology and Drug Safety published by John Wiley & Sons Ltd. Purpose: Comparative gastrointestinal bleeding (GIB) risk between rivaroxaban and low-dose aspirin is unknown in patients with atrial fibrillation (AF). This study investigated GIB risk with rivaroxaba...
Saved in:
Main Authors: | Laura Fanning, Ian C.K. Wong, Xue Li, Esther W. Chan, Pajaree Mongkhon, Kenneth K.C. Man, Li Wei, Wai K. Leung, Peteris Darzins, Simon Bell, Jenni Ilomaki, Wallis C.Y. Lau |
---|---|
格式: | 雜誌 |
出版: |
2020
|
主題: | |
在線閱讀: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85090958669&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/70971 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
相似書籍
-
Associations between genetic factors and bleeding in Thai atrial fibrillation patients using rivaroxaban
由: Andro Ranti
出版: (2023) -
Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: Comparison of high- and low-dose rivaroxaban with aspirin
由: Kochawan Boonyawat, et al.
出版: (2022) -
Patterns and factors influencing oral anticoagulant prescription in people with atrial fibrillation and dementia: Results from UK primary care
由: Pajaree Mongkhon, et al.
出版: (2020) -
Oral anticoagulant and reduced risk of dementia in patients with atrial fibrillation: A population-based cohort study
由: Pajaree Mongkhon, et al.
出版: (2020) -
Anti-factor xa activity of standard and Japan-specific doses of rivaroxaban in thai patients with non-valvular atrial fibrillation
由: Wanwarang Wongcharoen, et al.
出版: (2020)